
Skin Research Stack
Three Vials, One Research Focus
The GLOW MAX Bundle is built around skin-and-repair research. The Glow blend combines GHK-Cu, BPC-157 and TB-500 in a single 70 mg vial, reinforced by a full-size GHK-Cu 100 mg vial — the copper complex of a naturally occurring tripeptide studied as a modulator of multiple cellular pathways in skin-regeneration research[7] — and a BPC-157 10 mg vial, a pentadecapeptide documented in tendon-healing models[1] and in angiogenesis models, with pro-angiogenic activity associated with VEGFR2 activation[3].
- Skin-and-repair research theme across three vials
- Glow blend — GHK-Cu, BPC-157 and TB-500 in one vial
- GHK-Cu — copper tripeptide, skin and remodelling research
- BPC-157 — tendon-healing and angiogenesis models
- Lot-specific third-party COA for each compound

Inside the Bundle
What's in the Stack
The bundle ships as three separate lyophilized vials: the Glow blend (70 mg), GHK-Cu 100 mg and BPC-157 10 mg. In preclinical models, GHK-Cu has been studied in skin and connective-tissue research[7], BPC-157 on fibroblast migration[1], and thymosin beta-4 — supplied as TB-500 inside the blend — in actin dynamics[5].
- Glow blend — 70 mg combination vial (GHK-Cu + BPC-157 + TB-500)
- GHK-Cu — 100 mg lyophilized vial
- BPC-157 — 10 mg lyophilized vial
- Copper-peptide chemistry + peptide repair signalling
- 10% saving versus buying the three vials separately

Research Applications
Areas of Scientific Investigation
Each compound has been studied separately: GHK-Cu was described as a modulator of collagen synthesis and remodelling pathways in skin-regeneration research[7] and transiently improved healing outcome in a rat model of ACL reconstruction[8]; in a rat model, BPC-157 accelerated healing of the transected Achilles tendon[2]; and thymosin beta-4 activated integrin-linked kinase and promoted cardiac cell migration, survival and repair[6]. No published study evaluates the three vials in combination; researchers using them side by side are combining independent lines of evidence.
- Skin-regeneration and remodelling research
- Collagen-synthesis and antioxidant-defence assays
- Wound-healing and angiogenesis assays
- Tendon, ligament and muscle injury models

Understanding the Glow Max Stack: Mechanism of Action
GHK-Cu is the copper complex of glycyl-L-histidyl-L-lysine, a tripeptide naturally present in human plasma whose levels decline with age. It has been studied as a modulator of multiple cellular pathways in skin regeneration — collagen synthesis, extracellular-matrix remodelling and antioxidant defence[7] — and, in a rat model of ACL reconstruction, transiently improved healing outcome[8]. The bundle carries it twice: inside the Glow blend and as a full 100 mg vial.
BPC-157 is a 15-amino-acid fragment of the Body Protection Compound found in gastric juice. In preclinical models it has been reported to promote tissue-repair signalling through several converging mechanisms: promotion of tendon-fibroblast outgrowth and migration, likely via the FAK–paxillin pathway[1], accelerated healing of transected tendon in a rat study[2], pro-angiogenic activity associated with VEGFR2 activation[3], and a documented relationship with the nitric-oxide system[4].
TB-500, the third component of the Glow blend, is synthetic full-length thymosin beta-4 (43 amino acids), identified as a principal G-actin-sequestering peptide. Thymosin beta-4 binds monomeric G-actin and regulates its polymerisation[5]; in a 2004 Nature study, it activated integrin-linked kinase and promoted cardiac cell migration and survival after injury[6].
Together, the three vials give researchers a skin-and-repair toolkit: copper-peptide chemistry (GHK-Cu, included twice), local repair signalling (BPC-157) and actin regulation (thymosin beta-4). Each pathway is supported by its own line of preclinical evidence; no published study evaluates the combination itself. These materials are supplied strictly for laboratory research use.
Scientific Literature
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80.
- Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-83.
- Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-333.
- Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr Pharm Des. 2014;20(7):1126-35.
- Safer D, Elzinga M, Nachmias VT. Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable. J Biol Chem. 1991;266(7):4029-32.
- Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-72.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
- Fu SC, Cheuk YC, Chiu WY, Yung SH, Rolf CG, Chan KM. Tripeptide-copper complex GHK-Cu (II) transiently improved healing outcome in a rat model of ACL reconstruction. J Orthop Res. 2015;33(7):1024-1033.
Packaged with care, shipped fast.
We’re a passionate team obsessed with quality, not margins.
- Company
- Price
- Purity
- Quantity
- Shipping
-
GLOW MAX Bundle
-
Prime
Lab PeptidesTypical
Competitor -
$270.00$485.00
- ≥99%96%
- 3 vials3 vials
- Free 2-Day Shipping3-10 Business Day
-